Biomarin Pharmaceutical Inc (NASDAQ:BMRN) - Share price


Stock Report

Biomarin Pharmaceutical Inc BMRN

Last Price
$82.47

Day Change
0.10|0.12%

As of 17/07/2019
17:53:35 EDT | USD
Minimum 15 Minutes Delay.

Last Close82.37
Day Range81.37 - 83.39
Mkt Cap14.77Bil
52-Wk Range79.13 - 106.74
Yield %-
ISINUS09061G1013
Volume703,517
P/E-161.71
P/S9.65
P/CF1,870.07

Share Price

Financials
201620172018
More ...
Income Statement
Revenue1,116.851,313.651,491.21
Operating Income-204.31-139.70-173.52
Net Income-630.21-117.04-77.21
Basic EPS-3.80-0.67-0.44
Avg. Diluted Shares Outstanding166174177
Balance Sheet
Current Assets1,421.792,207.142,056.22
Non Current Assets2,601.902,425.982,370.91
Total Assets4,023.694,633.134,427.13
Current Liabilities439.31816.52523.24
Total Liabilities1,257.421,824.461,459.19
Total Equity2,766.282,808.662,967.94
Cash Flow
Operating Cash Flow-227.84-8.7620.21
Capital Expenditure-148.38-199.22-144.62
Free Cash Flow-376.22-207.98-124.41

In millions, except "Basic EPS". Currency is USD.

Company Profile

Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

2,849
Key Stats
More ...
Price/Earning TTM-161.51
Price/Book5.02
Price/Sales TTM9.64
Rev Growth (3 year avg)18.78
EPS Growth (3 year avg)-
Operating Margin % TTM-11.64
Net Margin % TTM-5.18
ROE TTM-2.67
Debt/Equity0.28
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.